- Home
- RITM vs ADMA Comparison
RITM vs ADMA Comparison
Compare RITM & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RITM
- ADMA
- Stock Information
- Founded
- RITM 2011
- ADMA 2004
- Country
- RITM United States
- ADMA United States
- Employees
- RITM N/A
- ADMA N/A
- Industry
- RITM Real Estate Investment Trusts
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RITM Real Estate
- ADMA Health Care
- Exchange
- RITM Nasdaq
- ADMA Nasdaq
- Market Cap
- RITM 6.1B
- ADMA 5.1B
- IPO Year
- RITM N/A
- ADMA N/A
- Fundamental
- Price
- RITM $12.27
- ADMA $17.20
- Analyst Decision
- RITM Strong Buy
- ADMA Strong Buy
- Analyst Count
- RITM 7
- ADMA 3
- Target Price
- RITM $13.71
- ADMA $27.67
- AVG Volume (30 Days)
- RITM 5.1M
- ADMA 3.3M
- Earning Date
- RITM 10-28-2025
- ADMA 08-06-2025
- Dividend Yield
- RITM 8.16%
- ADMA N/A
- EPS Growth
- RITM 9.18
- ADMA 469.09
- EPS
- RITM 1.30
- ADMA 0.85
- Revenue
- RITM $3,665,023,000.00
- ADMA $474,174,000.00
- Revenue This Year
- RITM N/A
- ADMA $21.08
- Revenue Next Year
- RITM $3.99
- ADMA $25.98
- P/E Ratio
- RITM $9.41
- ADMA $20.26
- Revenue Growth
- RITM 16.59
- ADMA 43.58
- 52 Week Low
- RITM $9.13
- ADMA $13.50
- 52 Week High
- RITM $12.62
- ADMA $25.67
- Technical
- Relative Strength Index (RSI)
- RITM 51.21
- ADMA 46.25
- Support Level
- RITM $12.23
- ADMA $16.87
- Resistance Level
- RITM $12.40
- ADMA $17.58
- Average True Range (ATR)
- RITM 0.16
- ADMA 0.52
- MACD
- RITM -0.03
- ADMA 0.04
- Stochastic Oscillator
- RITM 27.55
- ADMA 45.91
About RITM Rithm Capital Corp.
Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company aims to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Its investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights) loans (including single-family rental), and consumer loans. Its operating segments are Origination and Servicing; Investment Portfolio; Residential Transitional Lending; and Asset Management.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.